1. Introduction {#sec1}
===============

Muscle mononuclear stem cells or Satellite Cells (SCs) are the major stem cells in postnatal skeletal muscle \[[@r1]\]. They play a role in the maintenance of muscle mass, remodeling, and hypertrophy during the lifespan. SCs are located in the space between the mature myofiber plasma membrane and basement membranes and are characterized by Pax7  positivity, MyoD1 negativity, and CD45^−^Sca-1^−^CD11b^−^CX CR4^+^β1-integrin^+^ cell surface marker expression in rodents \[[@r2], [@r3]\]. SCs serve as a nuclear reserve and are critical for muscle regeneration following an injury, and exercise-induced muscle hypertrophy. In normal conditions, SCs are in a quiescent state, which is a state of cellular hibernation. Upon stimuli; such as myofiber damage, mechanical stretching, cytokines, electrical stimulation, nitric oxide or growth factors (i.e. fibroblast growth factor (FGF), Hepatocyte Growth Factor (HGF) and insulin-like growth factor (IGF)-1), SCs are temporarily activated, and become MyoD1^-/+^ \[[@r4]\]. Activated SCs enter the cell cycle and undergo self-renewing proliferation, giving rise to additional SCs and further differentiating MyoD1^+^myoblasts \[[@r2]\].

Aging is accompanied by a time-dependent accumulation of damage in the cells. Long-lived stem cell populations can evade the effects of aging by quiescence (state of temporal cell cycle arrest), which provides protection against the stress associated with cellular proliferation, thereby, limiting cellular damage \[[@r5]\]. However, as described earlier, these cells are not dormant and can start proliferation upon stimulation. Aging is associated with the inability to maintain stem cell quiescence, which increases the chances of stem cell damage, and results in a loss of stem cell self-renewal and regenerative capacity \[[@r6]\]. These senescent cells are metabolically active, but irreversibly lose their proliferative capacity, and undergo extensive changes in protein expression and secretion; such as inflammatory cytokines, growth factors, Extracellular Matrix (ECM) components and proteases, ultimately developing the Senescence-Associated Secretory Phenotype (SASP) \[[@r7]\]. During aging, senescent cells accumulate, and the secreted pro-inflammatory cytokines, *e.g*. Tumor Necrosis Factor Alpha (TNFα) and Interleukin 6 (IL6), increase tissue inflammation \[[@r8]\]. Prolonged inflammation inflicts damage to tissues, which together with increased stem senescence and decreased regeneration, leads to tissue degeneration.

In skeletal muscle, aging is manifested by loss of SCs \[[@r9]\]. Moreover, the remaining SCs present reduced capacity for self-renewal, and stretch-induced activation leading to sarcopenia \[[@r10], [@r11]\]. These age-related degenerative losses of muscle mass, quality, and function take place in the absence of any underlying disease. Skeletal muscle is eventually replaced by fatty and fibrous tissue, which results in functional impairment of the muscle and hence, physical disability. Aging is also accompanied by constant, low-level inflammation in the body of the elderly \[[@r12], [@r13]\]. While temporal inflammation is required for SC activation and proliferation during muscle regeneration, continuous inflammation in SC niche depletes SCs, triggers protein catabolism, and impairs anabolic processes of skeletal muscle \[[@r14], [@r15]\]. Thus, increased inflammation and impaired SC function are thought to result in the observed sarcopenia of the elderly \[[@r16], [@r17]\].

In the present paper, using global gene expression and gene set enrichment analysis, we aimed to characterize the aging process in SCs. We found that aging is associated with increased expression of genes involved in myogenesis and muscle contraction, indicating loss of the stem cell properties. Moreover, we present the unique SASP for SCs, characterized by increased expression of various growth factors, ECM-, and inflammation-related genes.

2. Materials and Methods {#sec2}
========================

2.1. Data Processing {#sec2.1}
--------------------

Gene expression data, obtained from Affymetrix Mouse Genome 430 2.0 Array, for 14 mouse muscle satellite cell (isolated by FACS based on CD45^−^Sca-1^−^Ter119^−^ Cxcr4^+^ β1-integrin^+^ cell surface marker pattern) samples (5 young, 2-month-old; 4 middle-aged, 12-month-old and 5 aged, 24-month-old samples) were retrieved from public Gene Expression Omnibus repository (GEO series GSE50821). For detailed cell isolation and hybridization protocol, see Sinha M supplementary materials \[[@r18]\]. Gene expression data from middle-aged and aged satellite cells were compared to young samples using the GEO2R platform (<https://www.ncbi.nlm.nih.gov/geo/geo2r/>). Equal value intensity distribution and cross-comparability of individual microarrays were confirmed using box-and-whisker plots. The significance of fold changes (FC) was tested with Moderated t-test adjusted by Benjamini-Hochberg False Discovery Rate (FDR) correction for multiple testing. Data were imported in Microsoft Access and list of differentially expressed genes (DEG) was generated by removing non-significantly changed transcripts based on 0.05 multiple-testing-adjusted p-value and 2-fold FC cut-off value.

2.2. Functional Profiling {#sec2.2}
-------------------------

In order to gain insight into the biological function of the given transcripts, we used the PANTHER (Protein Analysis Through Evolutionary Relationships) Classification System (<http://pantherdb.org/>) to identify over-represented canonical pathways (Reactome pathways), biological processes and functions (Gene Ontology) among the DEGs. Duplicated transcripts were removed from the DEG list, and statistically significant enrichment of genes within Reactome pathways and GO categories was determined using Fisher\'s Exact test with FDR multiple test correction (FDR\< 0.05).

2.3. Clustering and Visualization of Data {#sec2.3}
-----------------------------------------

DEGs between young, middle-aged and aged SCs were clustered with Cluster software (M. Eisen, 1999 <http://rana.lbl.gov/EisenSoftware.htm>) using a Self-Organizing Map (SOM) with 1,000,000 iterations and 4 nodes. The log2 transformed FC values of genes in selected PANTHER analysis terms and the result of SOM clustering were visualized using heatmaps generated by TreeView software (M. Eisen, 1999 (<http://rana.lbl.gov/EisenSoftware.htm>).

3. Results {#sec3}
==========

3.1. Differentially Expressed Genes During SC Aging {#sec3.1}
---------------------------------------------------

Based on 2-fold change and p \<0.05 significance level in all age groups, we identified 606 transcripts with altered gene expression during mouse SCs aging in the analyzed GEO database. 136 transcripts showed decreased gene expression in aged samples and 137 in middle-aged group. The top 50 upregulated and downregulated genes in aged SCs are listed in supplementary Table **1** and **2**, respectively. The

average FC of decreased transcripts was -1.97 ± 1.31 in aged and -2.18 ± 1.25 in middle-aged group. The median FC value of decreased transcripts was -2.03 in aged and -2.15 in middle-aged groups. 470 transcripts showed increased gene expression in aged samples and 469 in middle-aged group. The average FC of increased transcripts was 3.27 ± 1.84 in aged and 2.82 ± 1.74 in middle-aged group. The median FC value of increased transcripts was 2.83 in aged and 2.45 in middle-aged group. Taken together, our results indicate progressive increasing changes in gene expression during SC aging.

3.2. Functional Profiling of Differentially Expressed Genes {#sec3.2}
-----------------------------------------------------------

To gain an insight into the biological processes that might be affected by aging in SCs, we carried out gene set enrichment analysis using the PANTHER Classification System tool. Our analysis revealed no statistically overrepresented GO-Slim Biological Process, GO-Slim Cellular Component or Reactome pathway among the genes that were downregulated in the middle-aged and aged SCs, as compared to SCs isolated from young mice. The same analysis revealed 5 GO-Slim Cellular Component (Table **[1](#T1){ref-type="table"}**), *e.g*., "actin cytoskeleton" and "extracellular space", 17 GO-Slim Biological Process categories (Table **[2](#T2){ref-type="table"}**); such as "Response to interferon-gamma" and "Muscle contraction" among the genes that were upregulated in the middle-aged and aged SCs when compared to young cells. We also found 22 Reactome pathways (*e.g*., "ECM organization", the non-protein ECM component "Keratan sulfate metabolism", and "Elastic fibre formation") which were significantly overrepresented among the upregulated genes (Table **[3](#T3){ref-type="table"}**). By investigating the genes belonging to Reactome pathways and PANTHER GO-Slim categories, we identified 18 genes associated with "Muscle contraction". 10 of them (Myl1, Mylpf, Tnni2, Tnnt3, Tnnc2, Tpm1, Tpm2, Myh4, Myh, and Myo1d) were already reported as upregulated genes in aged, 24-month-old SCs by Sinha M and coworkers, and therefore, not shown in [Fig. (**[1](#F1){ref-type="fig"}**)](#F1){ref-type="fig"} \[[@r18]\]. Genes related to muscle contraction and myogenic differentiation showed a significantly increased expression during SC aging (FC middle-aged 2 *vs*. FC aged 4, p \< 6.8e^-6^). We identified 22 genes related to "ECM organization" (*e.g*., Adamts2, Col8a1, Icam1, Itgb5, and Thbs1) which were significantly upregulated during SC aging (Fig. **[2](#F2){ref-type="fig"}**). Based on our analysis, functional profiling of the DEGs reveals increased extracellular protein secretion, myogenic differentiation, ECM protein production, deposition, and maturation in aging SC cells.

3.3. Identification of SASPs in SCs {#sec3.3}
-----------------------------------

Since increased protein secretion and ECM-related protein expression is a feature of SASP, we extended the search in our DEG list for genes which are known SASP members in epithelial cells and fibroblasts \[[@r7]\]. The SASP expression profile may differ in various cell types, therefore, we searched for reported SASP member-related genes as well. Besides the already in [Fig. (**[2](#F2){ref-type="fig"}**)](#F2){ref-type="fig"} presented ECM-associated genes we found 35 genes which were reported as SASP members in other cell types, or are related to an already categorized SASP gene. The expression pattern and log2 transformed fold-change values of the individual transcript are shown in [Fig. (**[3](#F3){ref-type="fig"}**)](#F3){ref-type="fig"}. The found genes can be divided into 6 main categories: interleukins, chemokines, growth factors, proteases and regulators, cell-cell interaction, and ECM components and processing enzymes.

4. Discussion {#sec4}
=============

In our study, we describe how mouse-derived SCs undergo profound gene expression changes during aging. These alterations in gene expression profile result in increased myogenic differentiation, ECM deposition, and maturation. In previous experiments, transcriptional analysis of sorted SCs isolated from old (22-, 24-month-old) mice, revealed that expression of myoD1; a marker of cycling and differentiation, was higher, while quiescent markers (cyclin-dependent kinase inhibitor 1B (cdkn1b/p27Kip1) and sprouty 1 (Spry1); an inhibitor of fibroblast growth factor (FGF) signaling) were expressed at lower level, compared to cells isolated from 6-month-old adults \[[@r19]\]. These gene expression changes were assumed to impair the ability of aged SCs to retain the quiescent state, driving them toward continuous proliferation and differentiation, leading to the depletion of the SC pool. In another study, transplantation of FACS-sorted SCs from geriatric mice (28-, 32-month-old) into young recipients showed that those SCs were unable to activate upon stimulation, enforcing the significance of cell-intrinsic alterations during SC aging \[[@r6]\]. One of the factors that the authors found to contribute to the reduced regenerative capacity was the upregulation of p16INK4A cyclin-dependent kinase inhibitor. In our analyis, the expression of myoD1, cdkn1b, Pax7, Spry1, and p16INK4A were not altered in the investigated 12- and 24-month-old mice groups (data not shown). However, statistical overrepresentation tests showed the upregulation of 18 genes associated with the actin-myosin machinery and muscle contraction. This indicates ongoing myogenic differentiation in SCs from old mice. Our results are also partially overlapping with the findings of Sinha and coworkers, who have identified 15 myocyte differentiation marker genes; Mylpf, Myl1, Mylc2b, TnnC2, and Tpm1-2, among others in aged SCs \[[@r18]\].

Senescent cells secrete a set of molecules which are defined as the SASP profile of the given cell type. These molecules encompass; among others, inflammatory cytokines, chemokines, growth factors, ECM components and modifying enzymes, which alter the microenvironment of aging cells. Our analysis confirmed the increased expression of IL6, IL1 superfamily member IL33, and Ccl2, found by Oh and coworkers. In addition, it revealed increased chemokine (*e.g*., Cx3cl1, Ccl11-19, and Cxcl9-16) expression during SC aging \[[@r20]\]. These molecules; activating broad spectrum of leukocytes and attracting neutrophils and macrophages, are contributing to the development of inflammation. The ECM modifier lysyl oxidase (LOX) enzyme is 4-fold upregulated in middle-aged and aged SCs \[[@r21]\]. Interestingly, LOX was shown to possess chemotactic activity for human peripheral blood mononuclear cells; accordingly, an increase in extracellular LOX protein amount might recruit additional inflammatory cells to aging muscle \[[@r22]\]. Another ECM modifier molecule which was two-fold upregulated in aging SCs was the secreted cysteine protease cathepsin K (Ctsk). Ctsk is one of the most potent mammalian collagenases, and its expression is induced by inflammatory cytokines \[[@r23]\]. Using Ctsk knockout mice, Ogasawara and coworkers found a decreased inflammatory marker expression, leukocyte migration and fibrosis after cardiotoxin-induced muscle injury in the absence of Ctsk, indicating a positive role of Ctsk in these processes \[[@r24]\]. Therefore, increased Ctsk expression in aging SCs could aggravate muscle inflammation in old mice. Although coordinated inflammation is required for muscle regeneration upon injury, the signs of persistent inflammation and absence of anti-inflammatory markers indicate aberrant muscle regeneration in aged muscles. Moreover, we have found increased expression of the protein cross-linking, ECM modifier enzyme tissue transglutaminase 2 (TG2) in aged SCs compared to young ones (3 and 3.4 fold upregulation in middle-aged and aged cells, respectively). TG2 expression is normally undetectable in postnatal skeletal muscle, but was found to be expressed in idiopathic inflammatory myopathies \[[@r25]\]. TG2 is known to be induced by several inflammatory cytokines, it also contributes to the initiation of inflammation by activating NF-κB pathway via posttranslational cross-linking and inactivation of NF-κB inhibitor (NF-κBi),which may contribute to the elevated NF-κB activity observed in aged SCs \[[@r26], [@r20]\]. Interestingly, we also found upregulation of NF-κBiε in aging SCs (2.5 and 2.6 fold increase in middle-aged and aged cells, respectively) which could partially limit harmful muscle inflammation. Inflammation induces ECM production in activated fibroblasts, which normally take place during muscle regeneration, however, this can lead to muscle fibrosis when the inflammation does not resolve properly \[[@r27]\]. In several pathological conditions, TGF-β was shown to augment epithelial-to-mesenchymal transition, thereby increasing the number of myofibroblast, resulting in the deposition of collagens, fibronectin, and proteoglycans, leading to fibrosis \[[@r28], [@r29]\].Through posttranslational modifications, TG2 plays a role in latent TGF-β production and activation; therefore, increased TG2 expression may promote muscle fibrosis \[[@r30], [@r31]\]. Not only fibroblasts are capable of ECM production, SCs were also shown to deposit collagen \[[@r32]\]. In our analysis, we detected upregulation of several of the ECM members; such as collagen 8, 11 and 12, matrix Gla protein, thrombospondin 2-4 and the Small Leucine-Rich Repeat Proteins (SLRPs), fibromodulin, osteomodulin, osteoglycin, and asporin in aged SCs. Additionally, exposure of SCs to an aged myomatrix directly inhibits myogenicity, and promotes a fibrogenic conversion of SCs, establishing a vicious circle of fibrotic transformation \[[@r33]\]. TG2 was implicated in ECM aging and subsequent ECM function decline by establishing protease resistant ε-(γ-glutamyl)-lysine crosslinks between several ECM components suggesting possible role in muscle aging \[[@r34]\]. Inhibition of TG2 activity proved to be efficient in the treatment of experimental fibrotic lung and kidney disease models in animals, and enzymatic digestion of ECM proteins is an emerging technique to alleviate symptoms of Dupuytren contracture, a disease characterized by fibrotic scar tissue accumulation and increased ECM stiffness \[[@r35]-[@r37]\].Therefore, inhibition of TG2 activity or removal of isopeptide crosslinks might offer a new therapeutic approach to slow down muscle fibrosis at old age.

All in all, our analysis of aging SCs revealed increased expression of genes involved in myogenic differentiation, accompanied by an elevated inflammatory cytokine-chemokine production, in addition to increased ECM protein and ECM modifying enzyme expression, which are hallmarks of muscle fibrosis. Together, these changes can contribute to the decrease in function and regenerative capacity of muscle fibers observed in sarcopenia at old age.

Regarding the limitation of the study, the microarray technology detects RNA transcripts, and has a decreased sensitivity in detecting low-abundance genes; therefore, it needs to be later verified by more sensitive quantitative PCR and protein detecting methods; such as Western blot and ELISA. In spite of these limitations, our study reveals novel features of satellite cell aging.

CONCLUSION
==========

In the present study, we describe the gene expression changes taking place in satellite cells during aging. We have found that aging leads to profound alterations, including increased expression of myogenic differentiation-, inflammation-, and fibrosis-related genes. The latter two categories represent the senescence-associated secretory phenotype for satellite cells. The altered gene expression pattern leads to decreased stem cell function and muscle regeneration capacity which results in age-associated muscle wasting.
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![Heatmap of 8 muscle contraction-related genes. Based on combined Reactome pathways and PANTHER GO-Slim category 8 new upregulated genes were identified in aged SCs associated with muscle contraction. Heatmap displays the log2 transformed FC values of middle-aged and aged mouse samples compared to young cells. Numbers inside the heatmap indicate the log2 transformed FC values of the given transcripts. FC: Fold Change.](CAS-11-165_F1){#F1}

![Heatmap of 22 ECM organization related genes. Based on Reactome pathways 22 upregulated genes were identified in aged SCs associated with ECM organization. Heatmap displays the log2 transformed FC values of middle-aged and aged mouse samples compared to young cells. Numbers inside the heatmap indicate the log2 transformed FC values of the given transcripts. FC: Fold Change.](CAS-11-165_F2){#F2}

![Heatmap of 35 SASP genes. Heatmap displays the log2 transformed FC values of middle-aged and aged mouse samples compared to young cells. Numbers inside the heatmap indicate the log2 transformed FC values of the given transcripts. The 35 genes can be divided into six categories and two sub-categories as indicated left to the panel. FC: Fold Change.](CAS-11-165_F3){#F3}

###### 

PANTHER GO-Slim Cellular Component overrepresentation test of genes upregulated in aged SCs compared to young ones. REF\#: number of reference genes in the given category; F\#: number of genes found among the upregulated genes in aging SCs; FDR: False Discovery Rate value calculated by Benjamini-Hochberg procedure for multiple test correction (FDR \< 0.05).

  **PANTHER GO-Slim Cellular Component**   **REF\#**   **F\#**   **Expected**   **Fold Enrichment**   **FDR**
  ---------------------------------------- ----------- --------- -------------- --------------------- ----------
  Lysosome                                 66          5         1              5                     4.43E-02
  Extracellular matrix                     95          7         1.4            4.9                   1.09E-02
  Actin cytoskeleton                       180         11        2.7            4.0                   3.16E-03
  Extracellular space                      643         29        9.8            3                     1.17E-05
  Extracellular region                     780         40        11.8           3.4                   3.40E-09

###### 

PANTHER GO-Slim Biological Process overrepresentation test of genes upregulated in aged SCs compared to young ones. REF\#: number of reference genes in the given category; F\#: number of genes found among the upregulated genes in aging SCs; FDR: False Discovery Rate value calculated by Benjamini-Hochberg procedure for multiple test correction (FDR \< 0.05).

  **PANTHER GO-Slim Biological Process**   **REF\#**   **F\#**   **Expected**   **Fold Enrichment**   **FDR**
  ---------------------------------------- ----------- --------- -------------- --------------------- ----------
  Response to interferon-gamma             60          8         0.91           8.78                  4.76E-04
  Immune system process                    278         11        4.22           2.61                  4.64E-02
  Muscle contraction                       107         13        1.62           8.00                  7.56E-06
  Cell-matrix adhesion                     51          6         0.77           7.75                  5.54E-03
  Cell growth                              45          5         0.68           7.32                  1.66E-02
  Growth                                   51          5         0.77           6.46                  2.13E-02
  Cytokine-mediated signaling pathway      69          6         1.05           5.73                  1.58E-02
  Response to external stimulus            319         19        4.84           3.92                  1.14E-04
  Locomotion                               256         14        3.89           3.60                  1.87E-03
  Cellular component morphogenesis         331         18        5.03           3.58                  4.88E-04
  Anatomical structuremorphogenesis        461         21        7.00           3.00                  6.69E-04
  Developmental process                    1580        43        23.99          1.79                  5.83E-03
  Nervous system development               231         10        3.51           2.85                  3.93E-02
  MAPK cascade                             324         14        4.92           2.85                  1.25E-02
  Proteolysis                              427         16        6.48           2.47                  1.82E-02
  Cellular component movement              414         15        6.29           2.39                  2.79E-02
  Cell differentiation                     458         16        6.95           2.30                  3.44E-02

###### 

PANTHER Reactome pathways overrepresentation test of genes upregulated in aged SCs compared to young ones. REF\#: number of reference genes in the given category; F\#: number of genes found among the upregulated genes in aging SCs; False Discovery Rate value calculated by Benjamini-Hochberg procedure for multiple test correction (FDR \< 0.05).

  **Reactome Pathways**                                               **REF\#**   **F\#**   **Expected**   **Fold Enrichment**   **FDR**
  ------------------------------------------------------------------- ----------- --------- -------------- --------------------- ----------
  Keratan sulfate degradation                                         11          6         0.2            35.9                  5.82E-05
  Keratan sulfate/keratin metabolism                                  30          8         0.5            17.6                  5.77E-05
  Glycosaminoglycan metabolism                                        112         11        1.7            6.5                   5.34E-04
  Metabolism of carbohydrates                                         259         18        3.9            4.6                   8.32E-05
  Metabolism                                                          1714        51        26.0           2.0                   9.87E-04
  Creatine metabolism                                                 7           3         0.1            28.2                  2.65E-02
  Cross-presentation of particulate exogenous antigens (phagosomes)   8           3         0.1            24.7                  3.44E-02
  Purine catabolism                                                   11          4         0.2            24.0                  6.85E-03
  Purine metabolism                                                   35          5         0.5            9.4                   2.35E-02
  Keratan sulfate biosynthesis                                        25          7         0.4            18.4                  9.68E-05
  Smooth Muscle Contraction                                           30          6         0.5            13.2                  2.40E-03
  Muscle contraction                                                  156         11        2.4            4.6                   5.69E-03
  Striated Muscle Contraction                                         33          6         0.5            12.0                  3.48E-03
  Molecules associated with elastic fibres                            32          5         0.5            10.3                  1.80E-02
  Elastic fibre formation                                             35          6         0.5            11.3                  4.26E-03
  Extracellular matrix organization                                   260         22        4.0            5.6                   4.92E-07
  Chemokine receptors bind chemokines                                 50          6         0.8            7.9                   1.75E-02
  Peptide ligand-binding receptors                                    179         11        2.7            4.1                   1.45E-02
  Collagen biosynthesis and modifying enzymes                         62          6         0.9            6.4                   3.53E-02
  Collagen formation                                                  89          8         1.4            5.9                   1.13E-02
  Integrin cell surface interactions                                  76          7         1.2            6.1                   1.96E-02
  Degradation of the extracellular matrix                             126         9         1.9            4.7                   1.80E-02
